Publications by authors named "Susan Strobel"

Claim this Profile
K
Knowledge, Attitudes, and Needs: Assessing the COVID-19 Impact in Rural America.
Susan Strobel, BreAnne Danzi, Susan Puumala, DenYelle Kenyon, Meghan O'Connell

S D Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose accuracy and injection force of disposable pens delivering pramlintide for the treatment of diabetes.
Douglas Merritt, Barb Schreiner, Scott Harris, Mary Beth DeYoung, Susan Strobel

J Diabetes Sci Technol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes.
Steve Edelman, Satish Garg, Juan Frias, David Maggs, Yan Wang, Susan Strobel

Diabetes Care· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Properties of pramlintide and insulin upon mixing.
Christian Weyer, Mark S Fineman, Susan Strobel, Larry Shen, Joann Data

Am J Health Syst Pharm· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects.
Tim Heise, Lutz Heinemann, Simon Heller, Christian Weyer, Yan Wang, Susan Strobel

Metabolism· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
Priscilla A Hollander, Philip Levy, Mark S Fineman, David G Maggs, Larry Z Shen, Susan A Strobel

Diabetes Care· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
Claresa Levetan, Laura L Want, Christian Weyer, Susan A Strobel, John Crean

Diabetes Care· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis